Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)
While acute administration may temporarily increase heart rate in some studies, long-term use typically results in sustained blood pressure reduction
Patients complete an online intake, are reviewed by a registered clinician, and, if appropriate, receive a prescription for semaglutide alongside weekly dietitian-led coaching sessions
Active or recent malignancy is treated as a hard contraindication in the clinical literature, and a history of hormone-sensitive cancer warrants specialist input
pause or cancel anytime Providers with expertise in womens health help you find the right treatment Unlimited messaging for questions, treatment adjustments, and side effect support Services, not offered in every state, include medical treatment of overweight and obesity including lifestyle counseling (e.g., diet and exercise) and prescription medications, if clinically appropriate, based on completion of required consultation
